FinanceCity
HealthcareNSE · BSE

Akums Drugs and Pharmaceuticals Limited

AKUMS · ISIN INE09XN01023

Share price

₹609 -1.78%

Market capitalisation

₹9322 CrClosed

Live from Yahoo Finance. Pulse animates during NSE market hours (9:15–15:30 IST, weekdays).

01 · Key metrics

Market cap

₹9322 Cr

Current price

₹609

-1.78% today

52W high

₹635

52W low

₹409

Stock P/E

36.5

P/B ratio

2.81

02 · Per share & returns

EPS (TTM)

₹16.68

Book value

₹217

ROE

8.02%

ROA

4.80%

Dividend yield

0.16%

Beta

03 · Financials (TTM)

By the numbers

Revenue

₹4359 Cr

+9.40% YoY

EBITDA

₹522 Cr

Net profit

₹255 Cr

-42.60% YoY

Profit margin

5.85%

Operating margin

9.64%

Total debt

₹157 Cr

Total cash

₹1681 Cr

Debt / equity

0.05x

Current ratio

3.25x

Payout ratio

0.00%

04 · Analyst view

Target price

₹690

Upside

+13.32%

Consensus

NONE

Analysts

3

05 · Shareholding pattern

Who owns AKUMS?

  • Promoters

    75.26%

    Founders & promoter group

  • Institutions

    13.38%

    FII + DII

  • Public

    11.36%

    Retail & non-institutional

As of 31 Mar 2026 · Source: NSE corporate filings

06 · Registration & listing

On the record

Symbol
AKUMS
Exchange
NSE · BSE
CIN
ISIN
INE09XN01023
BSE code
544222
Sector
Healthcare
Industry
Healthcare
Face value
₹2
Listing date
05 Aug 2024
Employees
Headquarters
Delhi, India

07 · About

What is Akums Drugs and Pharmaceuticals Limited?

Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. The company provides drugs, ayurvedic, herbals, toiletries, nutraceuticals, food and dietary supplements, derma and cosmetics, healthcare and hospital products, over-the-counter (OTC) products, active pharmaceutical ingredients, excipients, and compounds. It also offers branded formulations on various dosage forms, including tablets, capsules, injectables, opthalmics, and soft gelatin capsules for therapeutic areas, such as gynaecology, cardiology, orthopaedics, pediatrics, and dermatology, as well as anti-infectives, pain management and gastroenterology. In addition, the company operates as pharmaceutical contract development and manufacturing company. The company was incorporated in 2004 and is based in Delhi, India.

08 · Common questions

Frequently asked

What is the CIN of Akums Drugs and Pharmaceuticals Limited?+

The Corporate Identity Number for Akums Drugs and Pharmaceuticals Limited is published in the MCA21 corporate master. FinanceCity backfills CIN values during weekly refreshes.

Who are the promoters of Akums Drugs and Pharmaceuticals Limited?+

Promoter holding in AKUMS is approximately 75.26%, as disclosed in the latest published shareholding pattern.

What is the market capitalisation of Akums Drugs and Pharmaceuticals Limited?+

Akums Drugs and Pharmaceuticals Limited (AKUMS) has a market capitalisation of approximately ₹9322 Cr, reflecting the most recent weekly refresh from the BSE scrip master.

09 · Adjacent

Other healthcare listings

Full sector →